Abstract

Human papillomavirus (HPV) vaccination represents a pivotal advancement in public health aimed at preventing HPV infections and associated diseases, including cervical, anal, and oropharyngeal cancers, as well as genital warts. This abstract explores the evidence and impact of HPV vaccination programs worldwide. The introduction of HPV vaccines has significantly reduced the prevalence of HPV infections and related morbidities, marking a substantial public health achievement. Despite challenges in vaccine uptake and misinformation, ongoing efforts in vaccination campaigns continue to demonstrate the effectiveness of HPV vaccines in reducing HPV-associated diseases. This abstract reviews current literature and epidemiological data to underscore the critical role of HPV vaccination in advancing public health initiatives globally.